Intellia Therapeutics (NTLA) Soars 19.7%: Is Further Upside Left in the Stock?

Intellia Therapeutics, Inc. (NTLA) shares ended the last trading session 19.7% higher at $24.47. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 72.1% gain over the past four weeks.The price rise can be attributed to growing investor optimism related to the company’s leading in vivo genome-editing candidates, nex-z and lonvo-z, which are being developed for treating transthyretin (ATTR) amyloidosis and hereditary a ...